GVHD
A joint release from both Accentia Biopharmaceuticals and Biovest international announced that
This article looks at GVHD symptoms. GVHD, Graft-versus-host-disease, is the most serious
According to a new study published in the New England Journal of Medicine, the risk of
A drug typically used in HIV treatment appears to help stem-cell transplant patients who are at
According to findings published in the journal Blood, Ohio researchers believe they
According to an abstract presented at this year's ASH meeting in San Diego, rates of relapse and
Graft-versus-host disease (GVHD) is a serious potential complication following a bone marrow
Acute Graft Versus Host Disease, often abbreviated as GVHD, is a serious and life-threatening
Finally - a potentially very reliable biomarker could help doctors determine which bone